Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

In-Stent Restenosis Post-Approval Study

ClinicalTrials.gov ID: NCT02542267

Public ClinicalTrials.gov record NCT02542267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Post-Approval Study of the GORE® VIABAHN® Endoprosthesis for the Treatment of In-Stent Restenosis (ISR) in the Superficial Femoral Artery (SFA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the ISR 14-04 study is to evaluate post-market safety and effectiveness of GORE® VIABAHN® Endoprosthesis for treatment of In-Stent Restenosis of the Superficial Femoral Artery.

Study identification

NCT ID
NCT02542267
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
W.L.Gore & Associates
Industry
Enrollment
108 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2015 (Type not available)
Primary completion
Jul 2019 (Actual)
Completion
Jul 2021 (Actual)
Last update posted
Oct 16, 2023

2015 – 2021

United States locations

U.S. sites
20
U.S. states
17
U.S. cities
19
Facility City State ZIP Site status
Mount Sinai Medical Center Miami Florida 33140 —
Kaiser Foundation Hospital Honolulu Hawaii 96819 —
Rockford CardioVascular Associates Rockford Illinois 61107 —
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 —
Cardiovascular Institute of the South Houma Louisiana 70360 —
Covenant Medical Center, Inc. Saginaw Michigan 48602 —
Munson Medical Center Traverse City Michigan 49684 —
Midwest Aortic and Vascular Institute (MAVI) North Kansas City Missouri 64116 —
New York University Langone Medical Center New York New York 10016 —
New York Presbyterian Hospital/Weill Cornell Medical Center New York New York 10065 —
North Carolina Heart and Vascular Raleigh North Carolina 27607 —
Sanford Health Fargo North Dakota 58122 —
Providence Heart Clinic Portland Oregon 97225 —
St. Vincent's Consultants in Cardiovascular Disease Erie Pennsylvania 16502 —
The Miriam Hospital Providence Rhode Island 02906 —
Greenville Hospital System Greenville South Carolina 29615 —
Texas Health Research - Presbyterian Heart and Vascular Dallas Texas 75231 —
Texas Health Research - Presbyterian Hospital of Plano Plano Texas 75093 —
Swedish Medical Center - Heart and Vascular Research Seattle Washington 98122 —
Charleston Area Medical Center Charleston West Virginia 25304 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02542267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 16, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02542267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →